| A2 Technologies–Agilent: investment, 201101–201102 acquisition €na of substantially all assets + employment of all employees by Agilent |
2011-01-19 |
| ABB–Extrel CMS: investment, 200404 management buyout of ABB mass spectrometer business by Extrel CMS |
2004-04-01 |
| Abimed–Kinesis: investment, 200801 acquisition |
2008-01-01 |
| Advion–Quintiles: investment, 201110 acquisition €na in cash of Advion BioServices division |
2011-10-26 |
| AES Laboratoire–Mérieux: investment, 201105 acquisition €183m of AES Laboratoire/AES Chemunex by bioMérieux |
|
| Agilent–Bruker Corp: investment, 201003–201005 acquisition $37.5m in cash of ICP-MS + laboratory GC + GC-triple Quad MS product lines of Varian |
2010-03-09 |
| Agilent–Linden LLC: investment, 201002 acquisition €na of Hycor Biomedical Inc from Agilent by private equity firm Linden LLC |
2010-02-03 |
| Agilent–SEVERAL: credit, 201007–201307 public offering $250m Senior Notes 2.5% due July 2013 |
2010-07-13 |
| Agilent–SEVERAL: credit, 201007–202007 public offering $500m Senior Notes 5% due July 2020 |
2010-07-13 |
| Ahura Scientific–Thermo Fisher: investment, 201001–201002 acquisition $145m in cash + milestone earnout |
2010-01-19 |
| Aishin Kohki–YMC: investment, 200805 acquisition 100% of Aishin Kohki Co Ltd by YMC Co Ltd |
2008-05-01 |
| AIXUV–Bruker Corp: investment, 201003 acquisition €na of assets of AIXUV GmbH by BEST |
2010-03-15 |
| Alicat Scientific–Halma: investment, 201011 acquisition $25.2m in cash |
2010-11-03 |
| Alpha Innotech–Cell Biosciences: investment, 200909–200910 aquisition $17.9m in cash $1.5/share by Cell Biosciences |
2009-09-08 |
| Analytica of Branford–PerkinElmer: investment, 200905 acquisition €na |
2009-05-05 |
| Analytical Perspectives of North Carolina–SGS: investment, 201204 acquisition |
2012-04-27 |
| Anser Laboratories–Scientific Analysis Laboratories: investment, 2008 acquisition 100% by SAL Ltd |
2008-01-01 |
| Applied Proteomics–SEVERAL: investment, 201202 financing round Series B $22.5m from Domain Assoc + Vulcan Capital + returning angel investors |
2012-02-07 |
| ArtusLabs–PerkinElmer: investment, 201103 acquisition by PerkinElmer |
2011-03-24 |
| Astrotech–Texas (govt): investment, 201003 investment $1.8m by TETF in 1st Detect Corp to support commercialisation of portable mass spectrometer |
2010-03-03 |
| Athena Diagnostics–Fisher Scientific: investment, 200603– acqu $283m in cash from Behrman Capital |
2006-03-16 |
| Bear Instruments–Varian: investment, 200103 acquisition $7.5m in cash subject to certain adjustments |
2001-03-02 |
| Beckman Coulter–Danaher: investment, 201102–201106 acqusition cash tender offer $6.8b $83.5/share announced |
2011-02-07 |
| Becton Dickinson–Corning: investment, 201204– acquisition $730m in cash of majority of BD Discovery Labware unit ANNOUNCED |
2012-04-10 |
| BioAnaLab–Millipore: investment, 200908 acquisition |
2009-08-10 |
| Biocius–Agilent: investment, 201103 acquisition €na |
2011-03-01 |
| Biocius–BioFrontier Partners: investment, 200912 Biocius spin-off from BioTrove supported by investors incl BioFrontier Partners |
2009-12-16 |
| Biocius–Catalyst Health Ventures: investment, 200912 Biocius spin-off from BioTrove supported by investors incl Catalyst Health Ventures |
2009-12-16 |
| Biocius–CB Health Ventures: investment, 200912 Biocius spin-off from BioTrove supported by investors incl CB Health Ventures |
2009-12-16 |
| Biocius–Echelon Ventures: investment, 200912 Biocius spin-off from BioTrove supported by investors incl Echelon Ventures |
2009-12-16 |
| Biocius–Excel Venture Management: investment, 200912 Biocius spin-off from BioTrove supported by investors incl Excel Venture Management |
2009-12-16 |
| Biocius–Fletcher Spaght: investment, 200912 Biocius spin-off from BioTrove supported by investors incl Fletcher-Spaght |
2009-12-16 |
| Biocius–SEVERAL: investment, 200912 Biocius spin-off from BioTrove supported by syndicate of seven investors |
2009-12-16 |
| Biocius–Vox Equity Partners: investment, 200912 Biocius spin-off from BioTrove supported by investors incl Vox Equity Partners |
2009-12-16 |
| Biocrates–ARAX Capital Partners: investment, 201003 financing round totalling €1.2m incl investor ARAX Capital Partners GmbH |
2010-03-25 |
| Biocrates–Austria (govt): credit, 201008 erp credit €3m in two tranches from aws 1st tranche paid already 8/10 |
2010-08-25 |
| Biocrates–MIG Funds: investment, –200905– existent portolio company of MIG Fonds |
2009-05-29 |
| Biocrates–SEVERAL: investment, 201003 financing round €1.2m incl investor ARAX Capital Partners GmbH |
2010-03-25 |
| Biognosys–SEVERAL: investment, 201110 financing round Series A CHF2.7m from Syngenta Ventures + Redalpine Capital I + ZKB + private investors |
2011-10-31 |
| Biognosys–Switzerland (govt): grant, 201201 grant CHF1.5m to Biognosys + Aebersold Group at ETH Zurich for developm of HRM-MS technology |
2012-01-03 |
| bioMérieux–Mérieux: investment, 201008 existent Institut Mérieux owns 59% of bioMérieux |
2010-08-12 |
| BioProb project–Germany (govt): grant, 200805–201004 grant from BMBF |
2008-05-01 |
| Biosensor GmbH–SAW Instruments: investment, 201002 acquisition of assets by SAW Instruments GmbH |
2010-02-01 |
| BioSystem Development–Agilent: investment, 201112 acquisition €na |
2011-12-01 |
| BioTrove–Life Technologies: investment, 200911–200912 acquisition €na |
2009-11-10 |
| BioTrove–SEVERAL: investment, 200804– IPO filed |
2008-04-01 |
| Blue Heron–OriGene: investment, 201008 acquisition of Blue Heron Biotechnology by OriGene Technologies |
2010-08-12 |
| Blue Ocean Biomedical–Danaher: investment, 201203 acquisition by Beckman Coulter Life Sciences |
2012-03-29 |
| BRAHMS–HBM: investment, 200909 EXIT DIVESTMENT sale of all shares from HBM BioVentures to Thermo Fisher Scientific Inc |
2009-09-03 |
| BRAHMS–Thermo Fisher: investment, 200909–200910 acquisition €330m incl debt + other liabilities |
2009-09-03 |
| Brown Univ–United States (govt): grant, 201007–201107 NIH grant $500k to upgrade Thermo LTQ MS into LTQ Orbitrap XL ETD hybrid MS |
2010-07-15 |
| Bruker AXS–Bruker Daltonics: investment, 200304–200306 merger becoming Bruker BioSciences |
2003-04-07 |
| Bruker BioSciences–Germany (govt): grant, 200512– BMBF grant for developm mass spec-based RA test by Bruker Daltonik + PANATecs + Univ Göttingen |
2005-12-20 |
| Bruker Corp–Bremen (govt): grant, 201007–201206 grant €262k Bruker Daltonik + Fraunhofer + Steinbeis for MALDI Imaging from WFB RnD Innovation Progr |
2010-07-01 |
| Bruker Corp–Bremen (govt): grant, 201009–201202 grant €218k to Bruker Daltonik + IWT Bremen for MALDI-TOF-MS from WFB PFAU programme |
2010-09-01 |
| Bruker Corp–Germany (govt): grant, 200805–201004 grant €112k to Bruker Daltonik GmbH Leipzig in BioProb project from BMBF |
2008-05-01 |
| Bruker Corp–Germany (govt): grant, 200901–201208 grant €364k to Bruker Daltonik GmbH in SysTec project from BMBF |
2009-01-01 |
| Bruker Corp–Germany (govt): grant, 201104–201403 grant €409k to Bruker Daltonik GmbH in MALDI-AMK 3D MALDI Imaging project from BMBF |
2011-04-01 |
| Bruker Corp–SEVERAL: credit, 201201–201701 Senior Notes $20m 3.16% Series 2012A Tranche A due 18 Jan 2017 |
2012-01-18 |
| Bruker Corp–SEVERAL: credit, 201201–201901 Senior Notes $15m 3.74% Series 2012A Tranche B due 18 Jan 2019 |
2012-01-18 |
| Bruker Corp–SEVERAL: credit, 201201–202201 Senior Notes $105m 4.31% Series 2012A Tranche C due 18 Jan 2022 |
2012-01-18 |
| Bruker Corp–SEVERAL: credit, 201201–202401 Senior Notes $100m 4.46% Series 2012A Tranche D due 18 Jan 2024 |
2012-01-18 |
| Bruker Corp–SEVERAL: investment, 201009– IPO filed with SEC for BEST with Bruker Corp intending to retain controlling interest |
2010-09-03 |
| Bruker Daltonics–Germany (govt): grant, 198907–199206 grant €394.3k for Bruker Daltonik GmbH for emission mass spectrometer from BMBF |
1989-07-01 |
| Bruker Daltonics–Germany (govt): grant, 198912–199306 grant €653.6k to Bruker Daltonik GmbH for developm laser mass spectrometer from BMBF |
1989-12-01 |
| Bruker Daltonics–Germany (govt): grant, 199107–199412 grant €376.7k to Bruker Daltonik GmbH from BMBF |
1991-07-01 |
| Bruker Daltonics–Germany (govt): grant, 199407–199706 grant €2.27m Bruker Daltonik GmbH for developm mass spectrometry in genome research from BMBF |
1994-07-01 |
| Bruker Daltonics–Germany (govt): grant, 199706–200101 grant €2.42m Bruker Daltonik GmbH for mass spec analyzer for DNA polymorphisms from BMBF |
1997-06-01 |
| Bruker Daltonics–Germany (govt): grant, 199805–200004 grant €74.6k for developm laser mass spectrometer for online analysis from BMBF |
1998-05-01 |
| Bruker Daltonics–SEVERAL: investment, 200004–200008 IPO $104m+15.6m common stock 8m+1.2m Nasdaq UBS Warburg LLC lead manager |
2000-04-14 |
| Bruker-Franzen Analytik–Bruker (DE): investment, 1980 acquisition by company Bruker from Karlsruhe (DE) |
1980-01-01 |
| Caliper–PerkinElmer: investment, 201109 acquisition $600m in cash $10.5/share announced |
2011-09-08 |
| CambridgeSoft–PerkinElmer: investment, 201103– acquisition by PerkinElmer announced |
2011-03-24 |
| CAMECA–AMETEK: investment, 2007 acquisition |
2007-01-01 |
| Caprotec–Berlin (govt): grant, 200812– grant €0.6m 2y for RnD of Capture Compounds + caproKits from State of Berlin + ERDF/EFRE |
2008-12-15 |
| Caprotec–Berlin (govt): investment |
2007-11-22 |
| Caprotec–Berlin (govt): investment, 200711–200801 seed financing round totalling €6m incl investor VC Fonds Berlin GmbH |
2007-11-22 |
| Caprotec–Berlin (govt): investment, 201005 financing round Series B totalling €4m incl returning investor VC Fonds Berlin GmbH |
2010-05-13 |
| Caprotec–Creathor Venture: investment, 200711–200801 seed financing round totalling €6m incl investor Creathor Venture |
2007-11-22 |
| Caprotec–Creathor Venture: investment, 201005 financing round Series B totalling €4m incl returning investor Creathor Venture |
2010-05-13 |
| Caprotec–LBBW: investment, 201011 financing round Series B €1m 2nd closing with sole investor LBBW Venture Capital GmbH |
2010-11-09 |
| Caprotec–SEVERAL: investment, 200711–200801 seed financing round €6m Creathor Venture + VC Fonds Berlin GmbH + ERP Startfonds + private investors |
2007-11-22 |
| Caprotec–SEVERAL: investment, 201005 financing round Series B €4m Creathor Venture + VC Fonds Berlin GmbH + ERP Startfonds + private investors |
2010-05-13 |
| Capture Device–Biomotif: investment, 2007 acquisition of Capture Device AB by Biomotif AB |
2007-01-01 |
| Carlo Erba–Fisons: investment, 1985 acquisition of Carlo Erba Strumentazione SpA by Fisons plc |
1985-01-01 |
| Case Western Univ–United States (govt): grant, 201007 grant $1.1m 4y from NIBIB for Protein Footprinting for Mark Chance at School of Medicine |
2010-07-01 |
| Cerilliant–Sigma-Aldrich: investment, 201012 acquisition €na of all outstanding shares |
2010-12-30 |
| ChromoTek–SEVERAL: investment, 201007 financing round €400k from High-Tech Gründerfonds + Bayern Kapital |
2010-07-14 |
| ChromTech–Daicel Chemical: investment, 200901 acquisition of ChromTech Ltd by Chiral Technologies Europe |
2009-01-05 |
| Ciphergen–Bio-Rad: investment, 200608– equity investment $3m as part of acqu ProteinChip System + ww technology rights to SELDI-TOF-MS |
2006-08-14 |
| Clearstone Central Laboratories–LabCorp: investment |
|
| Clearstone Central Laboratories–LabCorp: investment, 201106– acquisition €na announced |
|
| Cohesive Technologies–Thermo Fisher: investment, 200612 acquisition |
2006-12-15 |
| Concept to Volume (C2V)–Thermo Fisher: investment, 200911 acquisition |
2009-11-13 |
| Correlogic–NONE: investment, 201007–201112 bankruptcy filed under Chapter 11 + finally assets sold to Vermillion Inc |
2010-07-16 |
| Correlogic–Vermillion: investment, 201112 acquisition of assets $435k in cash after Correlogic filed bankruptcy filed under Chapter 11 in July 2010 |
2011-12-02 |
| CovalX–Switzerland (govt): grant, 2007– KTI grant for co-developm of cross-linking molecules with Prof Renato Zenobi ETHZ + ABI |
2007-01-01 |
| CovalX–Switzerland (govt): grant, 201202– KTI grant €300k for co-developm methods analysis of protein-protein interactions w Swiss academic partner |
2012-02-01 |
| Creon Lab Control–Waters: investment, 2003 acquisition |
2003-01-01 |
| Danaher–PerkinElmer: investment, 201002– acquisition remaining 50% of MDS/PerkinElmer ICP-MS joint venture by PerkinElmer |
2010-02-26 |
![[MSC] Mass-Spec-Capital.com The Mass Spectrometry Web Portal](/images/basics/msc-mass-spectrometry-portal-logo.jpg){kind=logo}
![Banner [iiito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
